FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2897094710> ?p ?o ?g. }

• W2897094710 endingPage "638" @default.
• W2897094710 startingPage "628" @default.
• W2897094710 abstract "Mutations in the collagen genes COL4A1 and COL4A2 cause Mendelian eye, kidney and cerebrovascular disease including intracerebral haemorrhage (ICH), and common collagen IV variants are a risk factor for sporadic ICH. COL4A1 and COL4A2 mutations cause endoplasmic reticulum (ER) stress and basement membrane (BM) defects, and recent data suggest an association of ER stress with ICH due to a COL4A2 mutation. However, the potential of ER stress as a therapeutic target for the multi-systemic COL4A1 pathologies remains unclear. We performed a preventative oral treatment of Col4a1 mutant mice with the chemical chaperone phenyl butyric acid (PBA), which reduced adult ICH. Importantly, treatment of adult mice with the established disease also reduced ICH. However, PBA treatment did not alter eye and kidney defects, establishing tissue-specific outcomes of targeting Col4a1-derived ER stress, and therefore this treatment may not be applicable for patients with eye and renal disease. While PBA treatment reduced ER stress and increased collagen IV incorporation into BMs, the persistence of defects in BM structure and reduced ability of the BM to withstand mechanical stress indicate that PBA may be counter-indicative for pathologies caused by matrix defects. These data establish that treatment for COL4A1 disease requires a multipronged treatment approach that restores both ER homeostasis and matrix defects. Alleviating ER stress is a valid therapeutic target for preventing and treating established adult ICH, but collagen IV patients will require stratification based on their clinical presentation and mechanism of their mutations." @default.
• W2897094710 created "2018-10-26" @default.
• W2897094710 creator A5002509723 @default.
• W2897094710 creator A5004353762 @default.
• W2897094710 creator A5007552903 @default.
• W2897094710 creator A5009980458 @default.
• W2897094710 creator A5027523903 @default.
• W2897094710 creator A5039418984 @default.
• W2897094710 creator A5054846899 @default.
• W2897094710 creator A5062100274 @default.
• W2897094710 creator A5070644005 @default.
• W2897094710 creator A5075829398 @default.
• W2897094710 creator A5081471979 @default.
• W2897094710 creator A5001616213 @default.
• W2897094710 date "2018-10-22" @default.
• W2897094710 modified "2023-10-15" @default.
• W2897094710 title "4-Sodium phenyl butyric acid has both efficacy and counter-indicative effects in the treatment of Col4a1 disease" @default.
• W2897094710 cites W1502624346 @default.
• W2897094710 cites W1849608740 @default.
• W2897094710 cites W1968026156 @default.
• W2897094710 cites W1970298553 @default.
• W2897094710 cites W1989736688 @default.
• W2897094710 cites W1996166396 @default.
• W2897094710 cites W2023371427 @default.
• W2897094710 cites W2032756767 @default.
• W2897094710 cites W2039111504 @default.
• W2897094710 cites W2048456744 @default.
• W2897094710 cites W2063734943 @default.
• W2897094710 cites W2066218332 @default.
• W2897094710 cites W2069117788 @default.
• W2897094710 cites W2070273704 @default.
• W2897094710 cites W2082432121 @default.
• W2897094710 cites W2089198803 @default.
• W2897094710 cites W2096252197 @default.
• W2897094710 cites W2096500584 @default.
• W2897094710 cites W2099540110 @default.
• W2897094710 cites W2113869585 @default.
• W2897094710 cites W2123872376 @default.
• W2897094710 cites W2126756606 @default.
• W2897094710 cites W2129649143 @default.
• W2897094710 cites W2129656993 @default.
• W2897094710 cites W2131053138 @default.
• W2897094710 cites W2131355460 @default.
• W2897094710 cites W2142301722 @default.
• W2897094710 cites W2145869447 @default.
• W2897094710 cites W2150204018 @default.
• W2897094710 cites W2162695141 @default.
• W2897094710 cites W2169164452 @default.
• W2897094710 cites W2169590742 @default.
• W2897094710 cites W2169675124 @default.
• W2897094710 cites W2170165089 @default.
• W2897094710 cites W2172177100 @default.
• W2897094710 cites W2172876010 @default.
• W2897094710 cites W2188742158 @default.
• W2897094710 cites W2263498456 @default.
• W2897094710 cites W2271802081 @default.
• W2897094710 cites W2344201261 @default.
• W2897094710 cites W2344975916 @default.
• W2897094710 cites W2545015629 @default.
• W2897094710 cites W2591100827 @default.
• W2897094710 cites W2601221906 @default.
• W2897094710 cites W2611771012 @default.
• W2897094710 cites W2777081520 @default.
• W2897094710 cites W2801914936 @default.
• W2897094710 cites W2803499602 @default.
• W2897094710 cites W2808078021 @default.
• W2897094710 cites W624824473 @default.
• W2897094710 doi "https://doi.org/10.1093/hmg/ddy369" @default.
• W2897094710 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6360271" @default.
• W2897094710 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30351356" @default.
• W2897094710 hasPublicationYear "2018" @default.
• W2897094710 type Work @default.
• W2897094710 sameAs 2897094710 @default.
• W2897094710 citedByCount "21" @default.
• W2897094710 countsByYear W28970947102019 @default.
• W2897094710 countsByYear W28970947102020 @default.
• W2897094710 countsByYear W28970947102021 @default.
• W2897094710 countsByYear W28970947102022 @default.
• W2897094710 countsByYear W28970947102023 @default.
• W2897094710 crossrefType "journal-article" @default.
• W2897094710 hasAuthorship W2897094710A5001616213 @default.
• W2897094710 hasAuthorship W2897094710A5002509723 @default.
• W2897094710 hasAuthorship W2897094710A5004353762 @default.
• W2897094710 hasAuthorship W2897094710A5007552903 @default.
• W2897094710 hasAuthorship W2897094710A5009980458 @default.
• W2897094710 hasAuthorship W2897094710A5027523903 @default.
• W2897094710 hasAuthorship W2897094710A5039418984 @default.
• W2897094710 hasAuthorship W2897094710A5054846899 @default.
• W2897094710 hasAuthorship W2897094710A5062100274 @default.
• W2897094710 hasAuthorship W2897094710A5070644005 @default.
• W2897094710 hasAuthorship W2897094710A5075829398 @default.
• W2897094710 hasAuthorship W2897094710A5081471979 @default.
• W2897094710 hasBestOaLocation W28970947101 @default.
• W2897094710 hasConcept C126322002 @default.
• W2897094710 hasConcept C134018914 @default.
• W2897094710 hasConcept C139447449 @default.
• W2897094710 hasConcept C142724271 @default.
• W2897094710 hasConcept C158617107 @default.

• next